Fig. 2From: Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathyRisk of 3-month outcomes in propensity-score matched exposure groups and comparison groups in the patients who had ever taken the drugs. (ARI: absolute risk increase, NNH: number need to harm, MI: myocardial infarction, PVD: peripheral vascular disease, DVT: deep venous thrombosis, PE: pulmonary embolism)Back to article page